Aicalc
Clinical decision support with 60+ evidence-based medical calculators and risk scores
Software · EmbeddedCompany source
Company profile
About MEDICA
AI Medica is a healthcare technology company that develops evidence-based automation tools for electronic health records (EHRs). The company's platform is designed to help healthcare providers improve patient outcomes, optimize reimbursement, and enhance physician satisfaction through automated clinical decision support and documentation improvement. AI Medica offers three core products: Aicode for inpatient and outpatient coding automation, Aipro for clinical decision support, and Aicalc for automated clinical calculations and risk stratification. The platform integrates seamlessly with existing EHR systems using SMART on FHIR technology, requiring no custom development resources. AI Medica's solutions automate over 60 clinical risk scores and calculations, including mortality prediction, infection risk, readmission risk, and various specialty-specific assessments. The company focuses on helping healthcare organizations succeed in value-based care contracts by making it easier for physicians to adhere to quality metrics while reducing documentation burden. By automating evidence-based coding and clinical calculations, AI Medica aims to eliminate under-billing and over-billing, decrease clinical documentation improvement queries, and provide auditable results that improve both revenue capture and care quality. The platform is designed with physician workflow optimization in mind, pulling relevant data automatically and delivering results in seconds.
Company description MEDICA official website
Primary marketPopulation Health & Healthcare Analytics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at MEDICA?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Acute Kidney Injury
- Alcoholic Hepatitis
- Atrial Fibrillation
- Bronchopulmonary dysplasia
- Cardiac Events
- Cardiovascular Disease
- Cirrhosis
- GI Bleeding
- Liver Disease
- Myocardial Infarction
- Necrotizing Fasciitis
- Neonatal conditions
- Pancreatitis
- Pneumonia
- Pulmonary Embolism
- Sepsis
- Venous Thromboembolism
Who it serves
- Health Systems
- Hospitals
- Physician Groups
Deployment & integration
Embedded deployment with recorded integration context.
Recorded integration context: SMART on FHIR compliant EHR systems.
Geographic context
MarketsUSA
Company sourceOfficial website
Company milestones
Platform expansion
Platform implements 60+ clinical risk scores and calculations; deployed at St Luke's Idaho health system
Partnerships
Recorded partners
- St Luke's Idaho
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Aicode
Evidence-based coding automation for accurate reimbursement and reduced documentation queries
Software · EmbeddedCompany source
Aipro
EHR automation platform for value-based care optimization
Platform · EmbeddedCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Angiopep-2-decorated bacterial outer membrane vesicles penetrate the blood-brain barrier for glioblastoma chemo-immunotherapy.Drug delivery · Dec 31, 2026
Glucagon-like peptide-1: a critical link between gut microbiota dysbiosis and degenerative musculoskeletal diseases.Gut microbes · Dec 31, 2026
Gallic acid-driven core-shell nanovehicles enable intestinal adhesion and adipose retention for enhanced oral bioavailability of cholecalciferol.Drug delivery · Dec 31, 2026
FEA-guided co-design of bubble microneedles: controlled tip separation for rapid transdermal and sublingual delivery.Drug delivery · Dec 31, 2026
Global research trends in ferroptosis in autoimmune diseases: a bibliometric and visual analysis (2018-2025).Autoimmunity · Dec 31, 2026
Oral self-assembly nanoemulsion drives in vivo hepatic stellate cell-targeting drug delivery in liver fibrosis.Drug delivery · Dec 31, 2026
Clinical validation
Clinical-trial records
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP StudyNCT05354778 · Sponsor · COMPLETED
Safety of Lactobacillus LB Postbiotic in Immunocompromised Paediatric Patients With Diarrhoeal DiseaseNCT07758933 · Sponsor · NOT YET RECRUITING
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersNCT07754279 · Sponsor · COMPLETED
Clinical Trial of the Safety and Tolerability of the Drug MMH-450 in Healthy VolunteersNCT07708623 · Sponsor · COMPLETED
HIBA-Institutional Registry of AmyloidosisNCT01347047 · Sponsor · COMPLETED
Cardiac Contractility Modulation in Chagas Heart DiseaseNCT05519046 · Sponsor · RECRUITING
Regulatory
Regulatory records
EASYCELL CELL LOCATORK092116 · 510k · May 12, 2010
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Decreased documentation improvement queries
Inpatient and outpatient coding
Increased reimbursement accuracy
Automated evidence-based coding
Improved physician satisfaction
Reduced documentation burden
Lightning fast chart review
Automated clinical calculations
Decreased total cost of care
Value-based care optimization
St Luke's Idaho
Clinical decision support and documentation improvement for hospitalists
Improved care delivery, documentation, and billing efficiency with automated risk stratification
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Adam Robison
Chief Medical Officer & Founder
06 · Company updates
Updates from MEDICA
Recent articles published on MEDICA's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
Mayo Clinic Study Reveals How Genetic Testing Is Rewriting Pulmonary Fibrosis Care Protocols
Integration of telomere length analysis and genetic sequencing into routine practice is changing diagnoses and treatment decisions for lung disease patients
Clinical AI · Jul 3, 2026
Lab-Grown Blood Vessels Show Promise in Reversing Heart Disease Damage
Preclinical studies reveal engineered vascular organoids can integrate with damaged heart tissue and restore blood flow, offering a regenerative alternative to traditional bypass surgery.
Clinical AI · Jul 3, 2026
How Tomorrow's Weather Could Predict Your Hospital's Mental Health Crisis Load
A decade-long analysis of 15 million NHS contacts reveals that daily weather fluctuations—from temperature swings to rainfall—significantly influence mental health service demand, opening new frontiers for AI-powered healthcare forecasting.
Mental & Behavioral Health · Jul 3, 2026
India Launches Unified Drug Database to Power Next-Generation Healthcare AI
New national registry standardizes pharmaceutical data across the world's most populous nation, creating infrastructure for AI-driven clinical tools and medication safety systems.
Policy & Regulation · Jul 3, 2026
AI-Powered Synthetic Heart Could End Animal Testing in Cardiac Device Development
Australian researchers have developed a soft robotic heart that uses artificial intelligence to replicate both healthy and diseased cardiac conditions, offering a breakthrough alternative for medical device testing.
Clinical AI · Jul 3, 2026
Robot Pharmacists Are Here: How AI-Powered Dispensing Could Solve Healthcare's Medication Error Crisis
Startup Queue emerges from stealth with autonomous pharmacy technology that eliminates human handling of medications while addressing critical workforce shortages.
Healthcare Operations · Jul 3, 2026
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Population Health & Healthcare Analytics
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.